Clinical trial
Alfuzosin for Voiding Dysfunction in Multiple Sclerosis (MS)
NCT00688948
Study timeline
Study start (unknown)2007-11-01Date precision: month
Registry last updated2011-06-27
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Multiple Sclerosisunresolved
Bladder Dysfunctionunresolved
Interventions
AlfuzosinDRUG · verified · RxNorm: alfuzosin
Sponsors & collaborators
Nova Scotia Health Authoritylead sponsor
Sanoficollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00688948 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.